Organoids Market Outlook 2026–2030 Highlighting Growth Drivers And Industry Trends

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Organoids Market Over The 2026–2030 Period?

The organoids market has seen substantial expansion in recent years. This market is projected to expand from $4.82 billion in 2025 to $5.9 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 22.3%. Its historical growth can be attributed to advancements in stem cell technology, an escalating demand for alternative models to animal testing, increased research in tissue engineering, growing investments in biotechnology R&D, and the prompt adoption of organoid models by academic research institutes.

The organoids market is anticipated to experience significant expansion in the coming years. This market is projected to reach $13.13 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 22.2%. This expansion during the forecast period is driven by factors such as the broader application of personalized medicine, an increase in partnerships between the pharmaceutical industry and organoid research firms, advancements in regenerative medicine projects, greater government and private investment in organoid-focused research, and the creation of organoid biobanks for disease modeling. Key trends for the forecast period encompass the increasing integration of organoids in drug discovery and personalized medicine, their expanding utilization in regenerative medicine and tissue engineering, a surge in organoid applications for infectious disease pathology research, the accelerated development of disease-specific organoids for precise therapeutic interventions, and the growing incorporation of organoid models in preclinical assessments of drug efficacy and toxicity.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10787&type=smp

Which Primary Drivers Are Impacting The Organoids Market Growth?

The growing incidence and prevalence of chronic and infectious diseases are projected to advance the organoid market. A chronic disease is characterized as a condition lasting over a year and requiring ongoing medical attention. Organoids have been utilized to study various chronic diseases and their respective treatments, providing immediate and reliable data on pathogen biology and for drug screening. Consequently, the rise in the incidence and prevalence of chronic and infectious diseases will bolster the organoid market. For example, in June 2024, the National Health Service, a UK-based publicly funded healthcare system, reported that 3,615,330 people registered with a GP were identified with non-diabetic hyperglycemia, also known as pre-diabetes, in 2023, which is an increase of almost a fifth (18%) compared to 3,065,825 in 2022. Thus, the increasing prevalence of chronic diseases will propel the organoid market.

How Is The Organoids Market Categorized Across Its Segment Groups?

The organoids market covered in this report is segmented –

1) By Product: Hepatic Organoid, Colorectal Organoid, Intestinal Organoid, Other Products

2) By Application: Developmental Biology, Disease Pathology Of Infectious Disease, Regenerative Medicine, Drug Toxicity And Efficacy Testing, Drug Discovery And Personalized Medicine, Other Applications

3) By End-User: Hospitals And Diagnostic Centers, Biotechnology And Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Hepatic Organoid: Hepatic Stem Cell-Derived Organoids, Primary Liver Cell-Derived Organoids, Liver Tumor Organoids

2) By Colorectal Organoid: Colonic Organoids, Rectal Organoids, Colorectal Cancer Organoids

3) By Intestinal Organoid: Small Intestinal Organoids, Enteroid Organoids, Intestinal Stem Cell-Derived Organoids

4) By Other Products: Pancreatic Organoids, Brain Organoids, Kidney Organoids, Lung Organoids

Which Trends Are Shaping Growth In The Organoids Market?

Leading companies in the organoids market are focusing on developing innovative platforms, such as organoid panel screening platforms, to accelerate preclinical oncology drug discovery and gain a competitive position. An organoid panel screening platform is a system designed for the examination of a collection of organoids. For example, in November 2023, Crown Bioscience, a US-based contract research organization (CRO) and JSR Life Sciences company, introduced OrganoidXplore, a groundbreaking large-scale organoid panel screening platform aimed at speeding up preclinical oncology drug discovery. This platform incorporates Crown Bioscience’s unique assay-ready (AR) organoid technology, exhibiting highly robust performance, faster project completion, and reduced costs compared to existing methods. OrganoidXplore offers reliable and reproducible drug response comparisons, representing a significant stride in preclinical drug screening by precisely mirroring the genomic, morphological, and pathophysiological characteristics of original tumors.

Which Firms Are Influencing Competition In The Organoids Market?

Major companies operating in the organoids market are Cellesce Ltd., STEMCELL Technologies, HUB Organoids, DefiniGEN, OcellO B.V., Organoid Therapeutics, InSphero AG, Axol Bioscience Ltd., TissUse GmbH, Epithelix Sàrl, SUN Bioscience, Prellis Biologics, Epistem, MIMETAS BV, Organoidsciences Ltd., Zenit Science, Biomorgan, TheWell Bioscience Inc., CN Bio Innovations Ltd., TARA Biosystems, Nortis Inc., Newcells Biotech, Known Medicine, Dynomics Inc., CHA Biotech Co Ltd, Tempus AI Inc.

Get The Full Organoids Market Report:

https://www.thebusinessresearchcompany.com/report/organoids-global-market-report

Where Is The Organoids Market Primarily Concentrated By Region?

North America was the largest region in the organoids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global organoids market size forecast period. The regions covered in the organoids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Organoids Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/organoids-global-market-report

Browse Through More Reports Similar to the Global Organoids Market 2026, By The Business Research Company

Polyurethane Foam Market Report 2026

https://www.thebusinessresearchcompany.com/report/polyurethane-foam-global-market-report

Structural Insulated Panels Market

https://www.thebusinessresearchcompany.com/report/structural-insulated-panels-market

Polyurethane Foam Mattress Market Report

https://www.thebusinessresearchcompany.com/report/polyurethane-foam-mattress-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795